Swedish intrauterine growth reference ranges of biometric measurements of fetal head, abdomen and femur.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 12 2020
Historique:
received: 08 05 2020
accepted: 11 12 2020
entrez: 1 1 2021
pubmed: 2 1 2021
medline: 11 5 2021
Statut: epublish

Résumé

Ultrasonic assessment of fetal growth is an important part of obstetric care to prevent adverse pregnancy outcome. However, lack of reliable reference ranges is a major barrier for accurate interpretation of the examinations. The aim of this study was to create updated Swedish national reference ranges for intrauterine size and growth of the fetal head, abdomen and femur from gestational week 12 to 42. This prospective longitudinal multicentre study included 583 healthy pregnant women with low risk of aberrant fetal growth. Each woman was examined up to five times with ultrasound from gestational week 12 + 3 to 41 + 6. The assessed intrauterine fetal biometric measurements were biparietal diameter (outer-inner), head circumference, mean abdominal diameter, abdominal circumference and femur length. A two-level hierarchical regression model was employed to account for the individual measurements of the fetus and the number of repeated visits for measurements while accounting for the random effect of the identified parameterization of gestational age. The expected median and variance, expressed in both standard deviations and percentiles, for each individual biometric measurement was calculated. The presented national reference ranges can be used for assessment of intrauterine size and growth of the fetal head, abdomen and femur in the second and third trimester of pregnancy.

Identifiants

pubmed: 33384446
doi: 10.1038/s41598-020-79797-8
pii: 10.1038/s41598-020-79797-8
pmc: PMC7775468
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22441

Commentaires et corrections

Type : ErratumIn

Références

Acta Obstet Gynecol Scand. 2018 Feb;97(2):168-179
pubmed: 29192969
Paediatr Perinat Epidemiol. 2019 Jan;33(1):47-56
pubmed: 30485470
Ultrasound Obstet Gynecol. 2018 Jul;52(1):44-51
pubmed: 29696704
Acta Obstet Gynecol Scand. 2018 Apr;97(4):440-444
pubmed: 29352467
BMC Pregnancy Childbirth. 2008 Jan 08;8:1
pubmed: 18179721
Acta Obstet Gynecol Scand. 2006;85(3):286-97
pubmed: 16553175
BJOG. 2014 Apr;121(5):556-65
pubmed: 24387345
Stat Med. 2019 Aug 30;38(19):3527-3539
pubmed: 30352489
Obstet Gynecol. 1981 Jan;57(1):18-21
pubmed: 7454172
Ultrasound Obstet Gynecol. 2018 Oct;52(4):488-493
pubmed: 29418032
Ultrasound Obstet Gynecol. 2004 Jul;24(1):42-50
pubmed: 15229915
Am J Obstet Gynecol. 2013 Nov;209(5):428.e1-6
pubmed: 23816839
Ultrasound Obstet Gynecol. 1993 Nov 1;3(6):378-84
pubmed: 12797237
BJOG. 2012 Nov;119(12):1425-39
pubmed: 22882780
Best Pract Res Clin Obstet Gynaecol. 2009 Dec;23(6):819-31
pubmed: 19632901
Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):172-85
pubmed: 16289532
PLoS Med. 2019 Sep 20;16(9):e1002902
pubmed: 31539391
BMJ. 2013 Jan 24;346:f108
pubmed: 23349424
Am J Obstet Gynecol. 2015 Oct;213(4):449.e1-449.e41
pubmed: 26410205
Acta Obstet Gynecol Scand. 1985;64(7):593-7
pubmed: 3909731
PLoS One. 2016 Jan 13;11(1):e0147109
pubmed: 26760299
Acta Obstet Gynecol Scand. 2017 Jan;96(1):86-95
pubmed: 27696340
Paediatr Perinat Epidemiol. 2008 Nov;22(6):587-96
pubmed: 19000297
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488
Ultrasound Obstet Gynecol. 2018 Jun;51(6):792-798
pubmed: 28452092
PLoS One. 2017 Jul 12;12(7):e0176331
pubmed: 28700705
Reprod Health. 2019 Jul 4;16(1):95
pubmed: 31272510
Ultrasound Obstet Gynecol. 2013 Jan;41(1):102-13
pubmed: 23280739
Ultrasound Obstet Gynecol. 2019 Jun;53(6):715-723
pubmed: 31169958
PLoS Med. 2017 Jan 24;14(1):e1002220
pubmed: 28118360
Ultrasound Obstet Gynecol. 2005 Mar;25(3):258-64
pubmed: 15717289
Acta Paediatr. 1996 Jul;85(7):843-8
pubmed: 8819552

Auteurs

Linda Lindström (L)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. linda.lindstrom@kbh.uu.se.

Mårten Ageheim (M)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Ove Axelsson (O)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.

Laith Hussain-Alkhateeb (L)

Global Health, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Alkistis Skalkidou (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Eva Bergman (E)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH